InsiderTrades.com logo
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

MAB1 Insider Trading

Insider Ownership Percentage: 20.29%
Insider Buying (Last 12 Months): £51,000.76
Insider Selling (Last 12 Months): GBX 0

Mortgage Advice Bureau Insider Trading History Chart

This chart shows the insider buying and selling history at Mortgage Advice Bureau by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mortgage Advice Bureau Share Price & Price History

Current Price: GBX 690
Price Change: ▲ Price Increase of +14 (2.07%)
As of 11/29/2023 01:00 AM ET

This chart shows the closing price history over time for MAB1 up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

Mortgage Advice Bureau Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/14/2023Lucy TilleyInsiderBuy46GBX 650£299
11/3/2023Lucy TilleyInsiderBuy147GBX 580£852.60
10/31/2023Nathan James McLean ImlachInsiderBuy330GBX 570£1,881
10/16/2023Lucy TilleyInsiderBuy54GBX 572£308.88
9/29/2023Nathan James McLean ImlachInsiderBuy345GBX 544£1,876.80
8/31/2023Nathan James McLean ImlachInsiderBuy324GBX 580£1,879.20
8/14/2023Lucy TilleyInsiderBuy46GBX 650£299
7/31/2023Nathan James McLean ImlachInsiderBuy285GBX 660£1,881
7/14/2023Lucy TilleyInsiderBuy56GBX 551£308.56
7/10/2023Ben ThompsonInsiderBuy4,777GBX 522£24,935.94
6/30/2023Nathan James McLean ImlachInsiderBuy320GBX 588£1,881.60
6/14/2023Ben ThompsonInsiderBuy40GBX 718£287.20
5/31/2023Nathan James McLean ImlachInsiderBuy260GBX 722£1,877.20
5/15/2023Ben ThompsonInsiderBuy36GBX 850£306
4/28/2023Nathan James McLean ImlachInsiderBuy238GBX 790£1,880.20
3/31/2023Nathan James McLean ImlachInsiderBuy271GBX 694£1,880.74
3/14/2023Lucy TilleyInsiderBuy44GBX 660£290.40
2/28/2023Nathan James McLean ImlachInsiderBuy306GBX 614£1,878.84
2/14/2023Lucy TilleyInsiderBuy44GBX 680£299.20
1/31/2023Nathan James McLean ImlachInsiderBuy330GBX 570£1,881
1/16/2023Lucy TilleyInsiderBuy58GBX 528£306.24
12/30/2022Nathan James McLean ImlachInsiderBuy318GBX 536£1,704.48
12/14/2022Lucy TilleyInsiderBuy56GBX 540£302.40
11/30/2022Nathan James McLean ImlachInsiderBuy282GBX 604£1,703.28
11/14/2022Lucy TilleyInsiderBuy42GBX 688£288.96
11/4/2022Lucy TilleyInsiderBuy106GBX 688£729.28
10/31/2022Nathan James McLean ImlachInsiderBuy277GBX 602£1,667.54
10/14/2022Ben ThompsonInsiderBuy62GBX 504£312.48
10/5/2022Ben ThompsonInsiderBuy16,764GBX 595£99,745.80
9/30/2022Nathan James McLean ImlachInsiderBuy263GBX 635£1,670.05
8/31/2022Nathan James McLean ImlachInsiderBuy176GBX 950£1,672
8/15/2022Ben ThompsonInsiderBuy30GBX 992£297.60
7/14/2022Lucy TilleyInsiderBuy34GBX 895£304.30
6/30/2022Nathan James McLean ImlachInsiderBuy183GBX 895£1,637.85
5/16/2022Lucy TilleyInsiderBuy30GBX 1,038£311.40
4/29/2022Nathan James McLean ImlachInsiderBuy141GBX 1,160£1,635.60
4/14/2022Lucy TilleyInsiderBuy22GBX 1,330£292.60
3/31/2022Nathan James McLean ImlachInsiderBuy144GBX 1,160£1,670.40
3/14/2022Lucy TilleyInsiderBuy28GBX 1,115£312.20
2/28/2022Nathan James McLean ImlachInsiderBuy145GBX 1,135£1,645.75
2/14/2022Ben ThompsonInsiderBuy24GBX 1,250£300
1/31/2022Nathan James McLean ImlachInsiderBuy126GBX 1,330£1,675.80
1/14/2022Lucy TilleyInsiderBuy20GBX 1,435£287
12/14/2021Ben ThompsonInsiderBuy24GBX 1,305£313.20
11/30/2021Nathan James McLean ImlachInsiderBuy123GBX 1,300£1,599
11/19/2021Ben ThompsonInsiderSell55,000GBX 1,333£733,150
11/15/2021Lucy TilleyInsiderBuy22GBX 1,325£291.50
10/29/2021Nathan James McLean ImlachInsiderBuy119GBX 1,335£1,588.65
10/14/2021Lucy TilleyInsiderBuy22GBX 1,340£294.80
9/30/2021Nathan James McLean ImlachInsiderBuy132GBX 1,205£1,590.60
9/14/2021Ben ThompsonInsiderBuy22GBX 1,360£299.20
8/31/2021Nathan James McLean ImlachInsiderBuy110GBX 1,450£1,595
8/16/2021Ben ThompsonInsiderBuy22GBX 1,420£312.40
7/30/2021Nathan James McLean ImlachInsiderBuy121GBX 1,315£1,591.15
7/14/2021Ben ThompsonInsiderBuy24GBX 1,250£300
6/14/2021Lucy TilleyInsiderBuy24GBX 1,240£297.60
6/11/2021Ben ThompsonInsiderSell29,631GBX 1,205£357,053.55
5/28/2021Lucy TilleyInsiderBuy73GBX 1,225£894.25
5/14/2021Ben ThompsonInsiderBuy24GBX 1,260£302.40
4/30/2021Nathan James McLean ImlachInsiderBuy139GBX 1,150£1,598.50
4/13/2021David PreeceInsiderSell3,079GBX 1,240£38,179.60
3/31/2021Nathan James McLean ImlachInsiderBuy139GBX 1,150£1,598.50
3/29/2021David PreeceInsiderSell600,000GBX 1,100£6,600,000
3/15/2021Lucy TilleyInsiderBuy26GBX 1,140£296.40
2/26/2021Nathan James McLean ImlachInsiderBuy167GBX 955£1,594.85
2/15/2021Lucy TilleyInsiderBuy30GBX 990£297
1/29/2021Nathan James McLean ImlachInsiderBuy179GBX 890£1,593.10
1/14/2021Ben ThompsonInsiderBuy34GBX 846£287.64
12/31/2020Nathan James McLean ImlachInsiderBuy183GBX 870£1,592.10
12/18/2020Lucy TilleyInsiderBuy36GBX 795£286.20
12/14/2020Lucy TilleyInsiderBuy36GBX 810£291.60
11/30/2020Nathan James McLean ImlachInsiderBuy211GBX 758£1,599.38
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Mortgage Advice Bureau (LON:MAB1)

78.67% of Mortgage Advice Bureau stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Mortgage Advice Bureau logo
Mortgage Advice Bureau (Holdings) plc, together with its subsidiaries, provides mortgage advice services in the United Kingdom. It offers proprietary technology and services, which includes adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digital marketing and website solutions. The company also provides advice on buying property, remortgaging, and buy-to-let mortgage products through mortgage intermediaries. In addition, it offers advice on protection and various insurance products, which includes life insurance, income protection, critical illness cover, buildings and contents insurance, and mortgage payment and mover protection. The company was incorporated in 2000 and is based in Derby, the United Kingdom.
Read More on Mortgage Advice Bureau

Today's Range

Now: GBX 690
Low: 666
High: 696

50 Day Range

MA: GBX 589.26
Low: 495
High: 694

52 Week Range

Now: GBX 690
Low: 406.64
High: 930

Volume

74,116 shs

Average Volume

82,585 shs

Market Capitalization

£394.20 million

P/E Ratio

3,631.58

Dividend Yield

4.11%

Beta

1.03

Who are the company insiders with the largest holdings of Mortgage Advice Bureau?

Mortgage Advice Bureau's top insider shareholders include:
  1. Ben Thompson (Insider)
  2. Lucy Tilley (Insider)
  3. Nathan James McLean Imlach (Insider)
Learn More about top insider investors at Mortgage Advice Bureau.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.